Note: This is a daily stock update and the information stands true as of 13/02/25, 09:00 CET.
Company update:
Sales came in slightly better than expected, with organic growth at 2.2%, just above our 2.1% forecast and the consensus estimate of 2%. Margins were in line with consensus, but FCF was stronger than expected at CHF10bn (vs. expectations of CHF9.5bn).
Outlook 2025 The EBIT margin is expected to exceed 16% (consensus at 16.2%, AlphaValue at 16.5% already). Cost savings will reach CHF300m in 2025.
Outlook 2027 The company reiterated its target of EUR2.5bn in annual cost savings by 2027 but disclosed higher-than-expected restructuring costs.
Expert opinion:
Our analyst believes the market will focus on these higher restructuring costs, making it too early to jump back in despite a positive rating and 17% upside. We are slightly more optimistic. The stock has seen a significant decline over the past few years and now trades at the lower end of its historical PE25 range (see graph below). While we do not expect a rapid rebound, the small topline beat is a positive signal. We believe the consensus downgrade cycle has now ended, and given the company’s fundamentals, the stock should eventually regain market favor.
For daily updates, subscribe to our newsletter and for detailed information, reach out to us at sales@alphavalue.eu